MRK vs HUM
By Alex · Tickerpine
Merck & Co., Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HUM |
|---|---|---|
| Price | $148.78 | $397.93 |
| Market cap | $367.07B | $47.78B |
| P/E ratio | 119.0 | 37.6 |
| ROE | 6.96% | 6.89% |
| Profit margin | 4.77% | 0.88% |
| Revenue growth | 5.10% | 26.20% |
| Dividend yield | 2.29% | 0.89% |
| Beta | 0.23 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HUM in plain English
- MRK is the bigger company — about 7.7× the market cap of HUM.
- HUM is cheaper on earnings (P/E 37.6 vs 119.0).
- MRK earns a higher return on equity (7% vs 7%).
- HUM is growing revenue faster (26% vs 5%).
- MRK has the higher dividend yield (2.29% vs 0.89%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.